Antheia
Antheia, Inc. is a Menlo Park, California synthetic-biology company that manufactures biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for essential medicines. Founded on Christina Smolke's Stanford research, Antheia engineers yeast strains that reconstruct long, complex plant biosynthetic pathways and ferment sugar into molecules previously obtainable only through agricultural cultivation, compressing production timelines from years to weeks. Commercial products include fermentation-derived thebaine, oripavine and scopolamine, with a development pipeline of 70+ KSMs and APIs spanning neurology, gastrointestinal and oncology programs. NOTE FOR THE CATALOG: Antheia's "APIs" are Active Pharmaceutical Ingredients, not web APIs — the company publishes no developer API, SDK, or machine-readable interface contract.
Antheia is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Synthetic Biology, and Pharmaceuticals.
Antheia’s developer surface includes engineering blog, support, and 15 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 2
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 8
The organization behind the API
Scroll for all 8
Other 3
Properties that don't map to a standard resource type